Article · 28 Feb 2025
ArticlePublished 3 May 2019
Iindividualized dose of Vancomycin for PatientÃ?¢Ã?â?¬Ã?â?¢s with Chronic Kidney Disease at a Government Hospital in Padang, West Sumatra, Indonesia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vancomycin is a narrow therapeutical index antibiotic used to treat a number of bacterial infections. This glycopeptide antibiotic is indicated for the medication of severe life-threatening infections by gram positive bacteria insensitives to other antibiotics. It is almost completely eliminated unchanged by renal. Vancomycin has potential toxic characteristic in patients with renal dysfunction. The aim of the study was to examine individualized dose of vancomycin in patients with chronic kidney disease at internal ward in a government hospital Padang. Computation of dose following pharmacokinetics dosing method. The research was arranged by observational retrospective method analyzed from 58 patient’s medical record during January 2015 – April 2016. 43 patients (74.1%) of chronic kidney disease were medicated using vancomycin. Patients of chronic kidney disease on stage of 2, 3, 4 and 5 were 12, 15, 6 and 10, respectively. Clearance of vancomycin in patients with chronic kidney disease on stage of 2, 3, 4 and 5 were 3.06 + 0.4, 1.88 + 0.28, 0.88 + 0.21, and 0.58 + 0.15 L/h, respectively. The elimination half-life of this drug on chronic kidney disease stage 2, 3, 4 and 5 patients were 9.65 + 2.09, 14.11 + 2.89, 24.48 + 5.44, and 51.27 + 17.16 h, respectively. While accumulation factor in patients with chronic kidney disease on stage of 2, 3, 4 and 5 were 0.33 + 0.12, 0.50 + 0.1, 0.67 + 0.09, and 0.49 + 0.006, respectively. Results showed that 30.23% patients received exceed dose based on pharmacokinetic dosing method calculation
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Der Pharmacia Lettre.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Muslim Suardi”
- BylineArticles whose byline prints “Raveinal”
- BylineArticles whose byline prints “Marissa Sofjan”
- BylineArticles whose byline prints “Akmal Djamaan”